{"id":47336,"date":"2022-08-16T15:02:01","date_gmt":"2022-08-16T13:02:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/"},"modified":"2022-08-16T15:02:01","modified_gmt":"2022-08-16T13:02:01","slug":"vitalconnect-appoints-amy-covert-as-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/","title":{"rendered":"VitalConnect Appoints Amy Covert as Chief Financial Officer"},"content":{"rendered":"
\n

\nAddition of Experienced Financial Leader Bolsters Strong Management Team<\/i>\n<\/p>\n

SAN JOSE, Calif.–(BUSINESS WIRE)–#vitalconnect<\/a>—VitalConnect\u00ae<\/sup>, Inc.<\/a>, a leader in remote and in-hospital wearable biosensor technology, today announced the appointment of Amy Covert to the position of Chief Financial Officer, effective August 8, 2022. Covert brings more than 20 years of experience to the role, in both public and private companies, primarily within healthcare. She joins VitalConnect from HoverTech International, a medical device company, where she had served as CFO since 2019. At HoverTech, Covert had responsibility for finance and accounting as well as the operational organization which included manufacturing, sourcing, customer service and logistics. Prior to HoverTech, she held various financial leadership roles at BioTelemetry, Inc., a remote cardiac monitoring company.\n<\/p>\n

<\/a><\/p>\n

\nCovert received her Master of Business Administration and a Certificate in Accountancy from Villanova University. She graduated with a Bachelor of Science in Finance and International Business from The Pennsylvania State University.\n<\/p>\n

\n\u201cAmy brings a wealth of experience in building high-performance finance teams and driving organizational change to VitalConnect,\u201d said Peter Van Haur, CEO of VitalConnect. \u201cOver the past few years, we\u2019ve attracted tremendous talent to the leadership team with the common goal of improving outcomes for physicians and patients. Adding a strong financial leader with Amy\u2019s experience will allow VitalConnect to accelerate our already rapid growth in cardiac monitoring and remote patient management.\u201d\n<\/p>\n

\nFounded in 2011, VitalConnect has deployed more than 200,000 patches throughout the world, including to leading acute-care facilities such as Brigham and Women\u2019s Hospital, Hackensack Medical Center, Northwell Health and John Radcliffe Hospital-Oxford University. The VitalPatch allows real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients.\n<\/p>\n

\nAbout VitalConnect, Inc.<\/b>\n<\/p>\n

\nVitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. VitalConnect leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. VitalConnect\u2019s products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions. For more information: www.vitalconnect.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contacts:
\n
Steve Kelly
\n
VitalConnect, Inc.
\n
206-856-6488
\n
skelly@vitalconnect.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Addition of Experienced Financial Leader Bolsters Strong Management Team SAN JOSE, Calif.–(BUSINESS WIRE)–#vitalconnect—VitalConnect\u00ae, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the appointment of Amy Covert to the position of Chief Financial Officer, effective August 8, 2022. Covert brings more than 20 years of experience to the role, in both public … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47336","6":"format-standard","7":"category-industry"},"yoast_head":"\nVitalConnect Appoints Amy Covert as Chief Financial Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VitalConnect Appoints Amy Covert as Chief Financial Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Addition of Experienced Financial Leader Bolsters Strong Management Team SAN JOSE, Calif.–(BUSINESS WIRE)–#vitalconnect—VitalConnect\u00ae, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the appointment of Amy Covert to the position of Chief Financial Officer, effective August 8, 2022. Covert brings more than 20 years of experience to the role, in both public ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-16T13:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220816005154\/en\/340733\/21\/VC_Logotype_FA3%28transp_bkgd%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"VitalConnect Appoints Amy Covert as Chief Financial Officer\",\"datePublished\":\"2022-08-16T13:02:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220816005154\\\/en\\\/340733\\\/21\\\/VC_Logotype_FA3%28transp_bkgd%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/\",\"name\":\"VitalConnect Appoints Amy Covert as Chief Financial Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220816005154\\\/en\\\/340733\\\/21\\\/VC_Logotype_FA3%28transp_bkgd%29.jpg\",\"datePublished\":\"2022-08-16T13:02:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220816005154\\\/en\\\/340733\\\/21\\\/VC_Logotype_FA3%28transp_bkgd%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220816005154\\\/en\\\/340733\\\/21\\\/VC_Logotype_FA3%28transp_bkgd%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VitalConnect Appoints Amy Covert as Chief Financial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VitalConnect Appoints Amy Covert as Chief Financial Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/","og_locale":"en_US","og_type":"article","og_title":"VitalConnect Appoints Amy Covert as Chief Financial Officer - Pharma Trend","og_description":"Addition of Experienced Financial Leader Bolsters Strong Management Team SAN JOSE, Calif.–(BUSINESS WIRE)–#vitalconnect—VitalConnect\u00ae, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the appointment of Amy Covert to the position of Chief Financial Officer, effective August 8, 2022. Covert brings more than 20 years of experience to the role, in both public ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-16T13:02:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220816005154\/en\/340733\/21\/VC_Logotype_FA3%28transp_bkgd%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"VitalConnect Appoints Amy Covert as Chief Financial Officer","datePublished":"2022-08-16T13:02:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/"},"wordCount":382,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220816005154\/en\/340733\/21\/VC_Logotype_FA3%28transp_bkgd%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/","url":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/","name":"VitalConnect Appoints Amy Covert as Chief Financial Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220816005154\/en\/340733\/21\/VC_Logotype_FA3%28transp_bkgd%29.jpg","datePublished":"2022-08-16T13:02:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220816005154\/en\/340733\/21\/VC_Logotype_FA3%28transp_bkgd%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220816005154\/en\/340733\/21\/VC_Logotype_FA3%28transp_bkgd%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vitalconnect-appoints-amy-covert-as-chief-financial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"VitalConnect Appoints Amy Covert as Chief Financial Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47336"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47336\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}